|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 诱导化疗后分割放疗治疗无法手术切除的头颈部鳞癌患者显示文摘该文旨在评价诱导化疗后再行分割放疗对无法切除的头颈部鳞癌患者的疗效。对1994~2000年间99例无法手术的头颈癌患者进行回顾性研究,67例T4,88例N2-N3。肿瘤部位:62例口咽部,22例下咽部,8例口腔,7例喉。 | Mesia R Majem M Barretina Ginesta | 2008 | 中国口腔颌面外科杂志2008，6，1： | 2 |
| 2 | Cetuximab may inhibit tumor growth and angiogenesis induced by ionizing radiation:a preclinical rationale for maintenance treatment after radiotherapy显示文摘 | Pueyo G Mesia R Figneras A | 2010 | Oncologist2010，15，9： | 1 |
| 3 | Platinum based chemotherapy plus cetuximab in head and neck cancer 显示文摘 | Vermorken J B Mesia R Rivera F | 2008 | N Engl J Med2008，359，11： | 1 |
| 4 | Platinum-based chemotherapy plus Cetuximab in head and neck Caneer显示文摘 | Vermorken J Mesia R Rivera F | 2008 | N Engl J Med2008，359，11： | 1 |
| 5 | 铂类化疗联合西妥昔单抗治疗转移或复发性头颈部鳞癌显示文摘研究背景:通常伴EGFR受体表达的头颈部鳞癌预后较差。西妥昔单抗(C-225)是一种可抑制EGFR的单克隆抗体,并可提高包括顺铂在内的多种细胞毒药物的疗效。随机临床研究结果显示,C-225在对铂类药物已出现耐药的复发或转移性头颈部鳞癌中具一定疗效。先前的数项Ⅱ期临床研究结果显示,顺铂或顺铂+5-Fu联合C-225为转移性头颈部鳞癌的有效一线治疗方案。 | Vermorken JB Mesia R Rivera F 陆嘉德 | 2009 | 中国癌症杂志2009，19，2： | 1 |
| 6 | SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma 2013显示文摘 | Mesia R Pastor M GrauJ J | 2013 | Clin Transl On?col2013，，： | 1 |
| 7 | Treatment of malignant vena cava syndrome by endovascular stent insertion experience on 52 patients with lung cancer显示文摘 | Urruticoechea A Mesia R | 2004 | Lung Cancer2004，43，： | 1 |
| 8 | Platinum-based chemotherapy plus cetuximab in head and neckcancer 显示文摘 | Vermorken J B Mesia R Rivera F | 2008 | N Engl J Med2008，359，11： | 1 |
| 9 | Clues to the pathogenesis of fal- lopian tube carcinoma: a morphological and immunohistoehemical case control study显示文摘 | Demopoulos I Aronov R Mesia A | 2001 | lnt J Gynecol Pathol2001，20，2： | 1 |
| 10 | Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer显示文摘 | Vermoken JB Mesia R Rivera F | 2008 | N Engl J Med2008，359，11： | 1 |
| 11 | Rapid palliation of symptoms with platinum-based chemotherapy plus cetuximab in recurrent oral cancer: A case report 显示文摘 | Mesia R Palmero R Cos M | 2010 | Head Neck Oncol2010，27，1： | 1 |
| 12 | Quality of life of patients receiving platinum-based chemotherapy plus cetux- imab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck 显示文摘 | Mesia R Rivera F Kawecki A | 2010 | Ann Oncol2010，8，5： | 1 |
| 13 | Hyperfractionatedradiotherapy:improvement of survival in locally advancednasopharyngeal carcinoma ]显示文摘 | Mesia R Manos M Nogues J | 2009 | Ann Otol Rhinol Laryn-gol2009，118，6： | 1 |
| 14 | Platinum-based chemotherapy plus cetuximab in head and neck cancer显示文摘 | Vermorken JB Mesia R Rivera F | | 0，，11： | 1 |
| 15 | Platinum-based chemotherapy plus cetuximab in head and neck cancer显示文摘 | Vermorken JB Mesia R Rivera F | 2008 | New Engl J Med2008，359，： | 1 |
| 16 | Platinum-based chemotherapy plus cetuximab in head and neck cancer 显示文摘 | Vermorken JB Mesia R Rivera F | 2008 | N Engl J Med2008，359，11： | 1 |
| 17 | In vitro antiplasmodial activity of extracts and fractions from seven medicinal plants used in the Democratic Republic of Congo显示文摘 | Tona L Cimanga R K Mesia K | 2004 | Journal of Ethnopharmacology2004，93，1： | 1 |
| 18 | Short-term health- related quality of life and symptom control with docetaxel, cisplat- in, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for in- duction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323)显示文摘 | Van Herpen CM Mauer ME Mesia R | 2010 | BrJ Cancer2010，103，8： | 1 |
| 19 | Platinum-based chemotherapy plus cetuximab in head and neck cancer显示文摘 | Vermorken JB Mesia R Rivera F | 2008 | N Engl J Med2008，359，11： | 1 |
| 20 | Short-term health-related quality of life and symptom control with doeetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locore-gionally advanced head and neck cancer patients (EOt/TC 24971/TAX 323) 显示文摘 | van Herpen CM Mauer ME Mesia R | 2010 | Br J Cancer2010，103，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员